We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.85B
AUM Growth
+$1.14B
Cap. Flow
+$1.07B
Cap. Flow %
22.01%
Top 10 Hldgs %
53.88%
Holding
153
New
63
Increased
23
Reduced
14
Closed
45

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$356M
2
AMZN icon
Amazon
AMZN
+$325M
3
AVGO icon
Broadcom
AVGO
+$218M
4
MON
Monsanto Co
MON
+$163M
5
STZ icon
Constellation Brands
STZ
+$155M

Top Sells

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$371M
2
AGN
Allergan plc
AGN
+$207M
3
LNG icon
Cheniere Energy
LNG
+$195M
4
CHTR icon
Charter Communications
CHTR
+$153M
5
MCD icon
McDonald's
MCD
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Energy 13.27%
3 Communication Services 10.39%
4 Technology 9.49%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
101
Salesforce
CRM
$154B
$302K 0.01%
+3,800
New +$298K
ALB icon
102
Albemarle
ALB
$13.4B
$254K 0.01%
+3,200
New +$235K
TRGP icon
103
Targa Resources
TRGP
$56.8B
$198K ﹤0.01%
+4,700
New +$184K
ONSIW
104
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$46K ﹤0.01%
+100,000
New +$38.3K
ONSIZ
105
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$45K ﹤0.01%
+100,000
New +$52.6K
ABBV icon
106
AbbVie
ABBV
$465B
– –
-2,250,000
Closed -$129M
ACAD icon
107
Acadia Pharmaceuticals
ACAD
$4.51B
– –
-150,000
Closed -$4.19M
AFMD
108
DELISTED
Affimed
AFMD
– –
-62,994
Closed -$2.36M
BHC icon
109
PUT
Bausch Health
BHC
$1.75B
– –
-21,500
Closed -$565K
CNC icon
110
Centene
CNC
$30.5B
– –
-500,000
Closed -$15.4M
COST icon
111
Costco
COST
$432B
– –
-37,800
Closed -$5.96M
CRL icon
112
Charles River Laboratories
CRL
$11.3B
– –
-19,698
Closed -$1.5M
DVAX
113
DELISTED
Dynavax Technologies
DVAX
– –
-300,000
Closed -$5.77M
EEM icon
114
iShares MSCI Emerging Markets ETF
EEM
$27.5B
– –
-1,494,100
Closed -$51.2M
FOLD
115
DELISTED
Amicus Therapeutics
FOLD
– –
-150,000
Closed -$1.27M
FXI icon
116
iShares China Large-Cap ETF
FXI
$4.32B
– –
-80,800
Closed -$2.73M
GLPI icon
117
Gaming and Leisure Properties
GLPI
$13B
– –
-122,900
Closed -$3.8M
HUM icon
118
Humana
HUM
$43.9B
– –
-239,000
Closed -$43.7M
INCY icon
119
Incyte
INCY
$25.8B
– –
-150,000
Closed -$10.9M
LNG icon
120
Cheniere Energy
LNG
$54.2B
– –
-5,770,277
Closed -$195M
LYB icon
121
LyondellBasell Industries
LYB
$19.5B
– –
-4,329,757
Closed -$371M
MGM icon
122
MGM Resorts International
MGM
$11.7B
– –
-188,500
Closed -$4.04M
NFLX icon
123
Netflix
NFLX
$307B
– –
-259,000
Closed -$2.65M
NOC icon
124
Northrop Grumman
NOC
$76B
– –
-363,670
Closed -$72M
QQQ icon
125
PUT
Invesco QQQ Trust
QQQ
$436B
– –
-43,500
Closed -$4.75M
2 3 4
5
6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q2 2016 Portfolio in Review

As of Q2 2016, PointState Capital held 153 positions worth $4.85B, up 31% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

PointState Capital deployed $1.07B of net new capital in Q2 2016, opening 63 new positions and adding to 23 existing holdings. Its largest new stake was Broadcom: 14,318,500 shares worth $223M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 38% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was Allergan plc, an estimated $207M trimmed.

  • PointState Capital's largest Q2 2016 buy was Broadcom: 14,318,500 shares worth $223M.
  • PointState Capital added most to Teva Pharmaceuticals in Q2 2016, an estimated $356M increase.
  • PointState Capital's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $207M.
  • PointState Capital fully exited LyondellBasell Industries in Q2 2016, selling an estimated $371M.
  • PointState Capital's ten largest holdings make up 54% of its $4.85B portfolio in Q2 2016.
  • PointState Capital opened 63 new positions and closed 45 in Q2 2016.
  • PointState Capital's portfolio value rose 31% quarter-over-quarter to $4.85B.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.